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Abstract
Background: In many eukaryotic cells, double-stranded RNA (dsRNA) triggers RNA interference
(RNAi), the specific degradation of RNA of homologous sequence. RNAi is now a major tool for
reverse-genetics projects, including large-scale high-throughput screens. Recent reports have
questioned the specificity of RNAi, raising problems in interpretation of RNAi-based experiments.
Results:  Using the protozoan Trypanosoma brucei as a model, we designed a functional
complementation assay to ascertain that phenotypic effect(s) observed upon RNAi were due to
specific silencing of the targeted gene. This was applied to a cytoskeletal gene encoding the
paraflagellar rod protein 2 (TbPFR2), whose product is essential for flagellar motility. We
demonstrate the complementation of TbPFR2, silenced via dsRNA targeting its UTRs, through the
expression of a tagged RNAi-resistant TbPFR2 encoding a protein that could be immunolocalized
in the flagellum. Next, we performed a functional complementation of TbPFR2, silenced via dsRNA
targeting its coding sequence, through heterologous expression of the TbPFR2 orthologue gene
from Trypanosoma cruzi: the flagellum regained its motility.
Conclusions: This work shows that functional complementation experiments can be readily
performed in order to ascertain that phenotypic effects observed upon RNAi experiments are
indeed due to the specific silencing of the targetted gene. Further, the results described here are
of particular interest when reverse genetics studies cannot be easily achieved in organisms not
amenable to RNAi. In addition, our strategy should constitute a firm basis to elaborate functional-
dissection studies of genes from other organisms.
Background
RNA interference (RNAi) can be triggered by introduction
of long double-stranded RNA molecules (dsRNAs) in cells
[1], and proceeds in a number of sequential steps, starting
with the cleavage of long dsRNAs into shorter ≈ 21–23
nucleotide-long dsRNAs called short interfering RNAs
(siRNAs; these were initially discovered in plants [2]). The
enzyme responsible for this chopping (DICER; [3,4]) dis-
plays RNase III activity, producing characteristic siRNAs
with a phosphorylated 5' end and a two nucleotide-over-
hanging 3'OH end. These siRNAs enter an RNA-induced
silencing complex, or RISC [5,6]. A helicase activity
unwinds the two strands of the siRNA, and RISC scans the
mRNAs in the cytoplasm and cleaves the molecules that
are found complementary to the RISC-contained siRNA
[5].
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RNA-silencing processes have been described in a variety
of organisms: post-transcriptional gene silencing in plants
[7,8], quelling in fungi [9], homology-dependent gene
silencing in ciliates [10], or RNA interference in worms
[1], flies [11,12], trypanosomes [13,14] and mammals
[15,16]. It is thought that this machinery has evolved to
protect cells against undesirable RNAs, like RNA viruses in
plants [17,18], or to limit the mobility of transposable ele-
ments in animals [19-21].
While RNAi and associated phenomena constitute excep-
tional recent basic science findings, they also provided a
basis for the elaboration of powerful research tools. RNAi
methodologies have been set up to perform reverse-genet-
ics studies in a number of organisms. RNAi potency and
flexibility have allowed to perform high-throughput
genetic screens in several organisms [22-26]. In mamma-
lian cells, the presence of long dsRNA (>50 base pairs)
triggers the activation of sequence-unspecific interferon-
related pathways [27-29]. To circumvent this difficulty,
researchers resorted to the transfection of small interfering
RNAs [16] or in vivo synthesis of small hairpin RNAs,
which were demonstrated to produce gene-specific silenc-
ing [27,30,31]; reviewed in [32,33].
However, an siRNA might trigger a number of potential
unspecific events such as the degradation of partially com-
plementary mRNA due to cross-hybridization, leading to
unspecific RNAi, or the translational arrest due to a micro
RNA-like effect where an siRNA hybridizes to a mRNA
with one or few mismatches. It is thus of paramount
importance to ensure that the phenotypic effects observed
as a result of siRNA presence in cells are due to silencing
of the target gene only. Two large-scale studies show that
siRNA-induced gene silencing of transiently- or stably-
expressed mRNA is highly gene-specific and does not pro-
duce secondary effects detectable by genome-wide expres-
sion profiling [34,35]. In contrast, other works provided
evidence that siRNAs can be target-unspecific, with the
observation of silencing of genes that had limited
sequence homology with the siRNA [36,37]. These reports
should prompt scientists to assess the specificity of RNAi-
silencing in any experiment. A solution to that problem,
that we devised in trypanosomes and which is described
in this report, is based on the rescueing of the RNAi-medi-
ated loss-of-function phenotype by expressing an RNAi-
resistant version of the target gene.
Trypanosomes are protozoan parasites belonging to the
Kinetoplastida order. These unicellular flagellated organ-
isms diverged very early in eukaryotic evolution, and
exhibit a number of original features [38-40]. Trypano-
somes were amongst the first organisms where RNAi was
discovered [13,14], and a number of strategies have been
devised to either transiently or permanently induce gene-
specific RNAi-silencing in these cells [14,41-43]. Exam-
ples of successful RNAi in trypanosomes used flagellar
genes as targets which yielded easily monitored pheno-
types [44]. From a structural point of view, the most con-
served morphological feature of eukaryotic flagella is the
axoneme, which is made of nine doublets of outer micro-
tubules plus 2 central microtubules (so-called 9+2 axone-
mal structure). In trypanosomes, the flagellum not only
has that axone-mal structure, but it also has a lattice-like
structure called the paraflagellar rod (PFR) that is posi-
tioned along the axoneme. The two main components of
the PFR are TbPFR2 and TbPFR1, that share 60% primary
sequence identity [45,46]. TbPFR2 silencing leads to flag-
ellar paralysis and trypanosomes do not swim anymore
[13,47]. During the cell cycle, the cell first replicates its
mitochondrial DNA (kinetoplast) and starts to grow a
new flagellum whilst maintaining the old flagellum in
place. Hence, a trypanosome which has two kinetoplasts
and two nuclei will be close to completion of its cell cycle
and will possess an old and a new flagellum [48]. This
aspect is an interesting feature for RNAi-based studies of
flagellar morphogenesis, because bi-flagellated cells have
an "internal control" flagellum (the old one), while the
new one has a phenotype corresponding to the RNAi-
based gene knock-down. The presence of both the old and
the new flagella in the same cell gives an indication of the
time course of events when RNAi is induced in trypano-
somes, leading to the appearance of a visible phenotype in
the new flagellum while the older one is unchanged
because it is not affected by gene silencing.
We previously established the degree of identity between
the gene sequences capable of leading to cross-RNAi
[47,49]. However, as mentioned earlier, each time a phe-
notype is observed in RNAi experiments, it is necessary to
ensure that it is indeed due to the specific silencing of the
targeted gene(s). Inspired by the procedure with which
gene knock-out is usually performed (the control experi-
ment is done by re-introducing the knocked-out gene to
ensure that the lost function gets complemented), we
devised a functional complementation strategy aimed at
assessing that RNAi indeed targets the intended gene. This
strategy, elaborated using the TbPFR2 gene as a model sys-
tem, involved the silencing of the TbPFR2 target via its
UTRs and the expression of a RNAi-resistant copy of the
targetted gene. The RNAi-resistant gene was either a copy
of TbPFR2 with different UTRs or its Trypanosoma cruzi
orthologue: TcPFR2. We found that inter-species comple-
mentation experiments were straight forward. This strat-
egy opens a venue for functional gene dissection
experiments where modified gene sequences can be tested
for their ability to encode functional protein that can
complement the RNAi-based loss-of-function phenotype.BMC Biotechnology 2005, 5:6 http://www.biomedcentral.com/1472-6750/5/6
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Results and discussion
Multiple RNAi on trypanosomes
We wanted to establish if the co-transfection of two dis-
tinct dsRNAs, targeting two different genes, could trigger
their simultaneous silencing. The genes selected were
TbPFR2 and FLA1; TbPFR2 encodes one of the two major
components of the paraflagellar rod and is necessary for
flagellum motility [13]; FLA1 encodes a protein required
for flagellum attachment to the cell body [50]. These dsR-
NAs were transfected simultaneously in wild-type
trypanosomes. As a control experiment, we used GFP
dsRNA.
Cells were monitored for their acquired phenotype 15 h
and 22 h after transfection (Table 1). The extinction of
TbPFR2 was followed by immunofluorescence micros-
copy using the L8C4 anti-TbPFR2 monoclonal antibody.
FLA1 gene silencing was analyzed by differential interfer-
ence contrast microscopy, as it results in the visible
detachement of the flagellum from the cell body (Figure
2).
The transfection of TbPFR2 dsRNA yielded potent silenc-
ing, as more than 60 % of the cells showed no staining for
L8C4 15 h later. Since old flagella pre-exist in cells which
were affected by RNAi at the beginning of cell replication,
the real percentage of silenced cells is probably higher
than 60 %, which is confirmed by the fact that it built up
to more than 74 % at time point 22 h. The transfection of
FLA1 dsRNA produced a phenotype in which the flagel-
lum was detached from the cell body in more than 50 %
of the cells. When both dsRNAs were co-transfected, both
phenotypes were indeed observed, with similar frequen-
cies to experiments where only one dsRNA was trans-
fected. All the transfected cell populations did show a
comparable growth rate (data not shown). The trypano-
somes shown in Figure 2 had been transfected with both
dsRNAs and the cell on the right is starting cytokinesis.
The old flagellum of that cell is detached, while the new
flagellum is attached along the cell body. The new flagel-
lum exhibits a dilation of its distal tip, probably corre-
sponding to the accumulation of TbPFR1, that is not
assembled but still transported to the distal tip of the flag-
ellum in the absence of TbPFR2 [13]. This observation
demonstrates the usefulness of double-transfection exper-
iments also for kinetics analysis. In our case, 22 h after
dsRNAs transient transfection, the phenotype due to the
FLA1 silencing is no longer visible in the new flagellum
while that same flagellum still exhibits the phenotype due
to the TbPFR2 silencing, clearly indicating different turn-
over for TbPFR2 and FLA1 proteins.
Table 1: Silencing effciencies after transfection of various dsRNAs. WT trypanosomes were transfected with TbPFR2, FLA1 or GFP 
dsRNA.
Time (hours)
dsRNA Phenotype (%) 0 h 15 h 22 h
TbPFR2 TbPFR2 silencing 0 61.2 (n = 1069) 74.2 (n = 1069)
FLA1 FLA1 silencing 0 56 (n = 586) 54 (n = 472)
TbPFR2 + GFP TbPFR2 silencing 0 56.2 (n = 301) 70.9 (n = 243)
TbPFR2 + FLA1 TbPFR2 silencing 0 53.6 (n = 349) 69.7 (n = 210)
FLA1 silencing 0 59 (n = 349) 53 (n = 210)
Silencing of FLA1 and TbPFR2 in Trypanosoma brucei Figure 2
Silencing of FLA1 and TbPFR2 in Trypanosoma bru-
cei. Wild type cells were simultaneously transfected with 
FLA1 and TbPFR2 dsRNA. At 22 h post-transfection, live cells 
were observed by differential interference contrast micros-
copy. Note the detached old flagellum and the dilation at the 
tip of the new flagellum (shorter one) of the rightmost cell.BMC Biotechnology 2005, 5:6 http://www.biomedcentral.com/1472-6750/5/6
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dsRNAs and plasmids used for transfections Figure 1
dsRNAs and plasmids used for transfections. (A) Not-to-scale schematic representation of the endogenous TbPFR2 
locus, with four copies of TbPFR2 coding sequence and specific UTRs. Regions targeted by RNAi are highlighted. The TbPFR2 
coding sequence was targeted using CDS dsRNA and the UTRs were targeted all together with a set of dsRNA homologous to 
the 3' UTR, the intergenic UTR (igUTR) and the 5' UTR (UTRs MIX dsRNAs). (B) Not-to-scale representation of the con-
structs used for the transfection of WT cells (pTbPFR2TAG430 and pTbPFR2TAG430-∆HLA; integration in the rDNA spacer) 
or TbPFR2i cells (pPCGFP and pPCTcPFR2; integration in the tubulin intergenic region). Large boxes represent protein coding 
sequences (black boxes: proteins of interest; grey boxes: antibiotic-resistance activities). Each plasmid was linearized with the 
indicated restriction enzyme prior to transfection into the cells. 3' ALD UTR: 3' UTR of the aldolase gene; ACT UTR: 5' or 3' 
UTR of the actin gene; EP ig reg: EP procyclin intergenic region; TUB ig reg: tubulin intergenic region.BMC Biotechnology 2005, 5:6 http://www.biomedcentral.com/1472-6750/5/6
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The RNAi machinery could cope with two different
dsRNA populations, without – in our conditions – any
visible saturation effect. These results show the feasibility
of experiments involving the use of multiple dsRNAs, thus
allowing studies on complex processes in the cell physiol-
ogy. However, such complex experiments can only be
envisaged after ensuring that the phenotypes resulting
from RNAi are specifically due to silencing of the target
gene. In order to address that specific problem, we elabo-
rated a method that involves RNAi experiments on
trypanosomes that were engineered to possess an extra
RNAi-resistant copy of the targeted gene, leading to func-
tional complementation.
Gene silencing by dsRNA targeting UTRs
As a model for this study, we chose the TbPFR2  gene,
which is present in four copies in the WT trypanosome
genome (Figure 1A), all transcribed as a single long poly-
cistronic mRNA. All these gene copies are separated by
three identical intergenic UTRs (igUTR), while the first
copy has a unique 5' UTR and the last copy has a unique
3'UTR. Three types of dsRNA populations were used in
our experiments, and termed as follows. dsRNA homolo-
gous to the GFP  sequence was labelled "GFP dsRNA";
dsRNA homologous to coding sequence of the TbPFR2
gene was labelled "CDS dsRNA"; finally, the mixture of
three dsRNAs homologous to the 5' UTR, igUTR and
3'UTR of the TbPFR2 gene was termed "UTRs MIX dsR-
NAs" (Figure 1A). These dsRNAs were transfected into
three cell lines: WT, TbPFR2tag and TbPFR2tag-∆HLA (see
Methods). For each experiment, the presence or absence
of TbPFR2 in the new flagellum of bi-nucleated/bi-flagel-
lated cells was monitored by immunofluorescence 14 h
after the transfection (Table 2).
Reports in [14,24] showed that RNAi silencing of a gene
can be accomplished by targeting transcribed non-coding
sequences. Here, we wanted to make sure that this kind of
experiment was still feasible with a more complex system
such as the TbPFR2 multigene locus, where multiple and
distinct UTRs regulate the expression of four TbPFR2 iso-
genes. We first transfected WT trypanosomes with GFP
dsRNA as a negative control and did not detect any
TbPFR2 silencing (Figure 3A). Second, WT trypanosomes
were transfected with the CDS dsRNA: 88 % of cells
showed typical TbPFR2  silencing with an anti-TbPFR2
immunofluorescence showing that the protein was miss-
ing from the new flagellum (Figure 3B). Finally, the WT
trypanosomes were transfected with the UTRs MIX dsR-
NAs, yielding the same phenotype as for the CDS dsRNA,
although the silencing appeared less pronounced (Figure
3C and Table 2). Overall, these results demonstrate that
RNAi could efficiently silence all of the TbPFR2  gene
copies by targeting non-coding sequences present at the
mRNA level.
When WT trypanosomes were transfected with TbPFR2
dsRNA complementary to only one UTR, the cells did not
display any specific phenotype (data not shown). This
observation is probably explained by the organization of
the TbPFR2 locus: the polycistronic transcript is rapidly
spliced into three different types of mRNA, each encoding
one of the four copies of TbPFR2 [51-53]. Thus, even if
one type of TbPFR2 RNA is destroyed, the three remaining
ones would likely provide enough RNA to synthesize
TbPFR2 levels compatible with normal PFR formation.
To demonstrate that the silencing observed upon transfec-
tion of WT trypanosomes with the UTRs MIX dsRNAs was
due to the actual targeting of TbPFR2, we used two cell
lines expressing a supplementary tagged TbPFR2  gene
copy. The TbPFR2tag cell line expresses the TbPFR2-TAG
protein which correctly localizes to the flagellum.
The  TbPFR2tag-∆HLA  cell line expresses TbPFR2-TAG-
∆HLA, lacking the HLA tripeptide, which prevents its
localization to the flagellum. To determine both the
cellular localization of the tagged TbPFR2 proteins
(TbPFR2-TAG and TbPFR2-TAG-∆HLA) and the com-
pleteness of the PFR assembly, immunofluorescence
Table 2: Silencing effciencies after transfection of various dsRNAs.
Cell line TbPFR2 silencing in the new flagellum (% bi-flagellated cells)
dsRNA transfected
TbPFR2 CDS TbPFR2 UTRs MIX
WT 88 % (n = 53) 62 % (n = 147)
TbPFR2tag 68 % (n = 113) 2 % (n = 51)
TbPFR2tag-∆HLA 78 % (n = 100) 72 % (n = 100)
WT, TbPFR2tag and TbPFR2tag-∆HLA trypanosomes were transfected with GFP, TbPFR2 CDS or TbPFR2 UTRs MIX dsRNAs and bi-nucleated/bi-
flagellated cells were counted for the status of their new flagellum. The data presented in this table correspond to the immunofluorescence 
experiment described in Figure 3 (see text for details).BMC Biotechnology 2005, 5:6 http://www.biomedcentral.com/1472-6750/5/6
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experiments were carried out with the BB2 and ROD-1
antibodies; the former recognizes the Ty-1 epitope tag
present on the two tagged TbPFR2 proteins [54], while the
latter is a marker for full PFR assembly [55,56].
GFP dsRNA was transfected as a negative control in each
cell line. As expected, this did not yield any TbPFR2 silenc-
ing: TbPFR2 was decorated in both the old and new flag-
ella by the anti-TbPFR2 antibody, and the PFR could be
assembled fully, as evidenced by its staining with the
ROD-1 antibody (data not shown, Table 2). In TbPFR2tag
cells, TbPFR2-TAG was able to localize to the PFR, as
evidenced by the PFR decoration with BB2 (red color, Fig-
ure 4A). In contrast, TbPFR2-TAG-∆HLA failed to do so in
TbPFR2tag-∆HLA cells, and the BB2 signal was detected in
the cytoplasm, as expected (red color, Figure 4D).
We next compared TbPFR2tag trypanosomes after trans-
fection with either CDS dsRNA or UTRs MIX dsRNAs.
TbPFR2tag cells transfected with CDS dsRNA had a flagel-
lum not (or faintly) decorated with the anti-TbPFR2 anti-
body, demonstrating that both the WT and the
recombinant TbPFR2 gene copies were effciently silenced
(Table 2). That result was confirmed with anti-TAG
immunofluorescence that showed no staining of the flag-
ellum, demonstrating that TbPFR2-TAG was absent (no
red color, Figure 4B). This lack of both TbPFR2 and
TbPFR2-TAG led to an incomplete assembly of the PFR,
which was therefore not decorated with the ROD-1 anti-
body (no yellow color, Figure 4B). In contrast, cells trans-
fected with the UTRs MIX dsRNAs exhibited a WT
phenotype, with only 2 % of the cells displaying TbPFR2
silencing in the flagellum (Table 2). In this case, the
tagged protein was expressed, leading to complete assem-
bly of the PFR (yellow color, Figure 4C) because the
protein is functional and localized to the flagellum (red
color, Figure 4C; [56]). This remarkable result indicates a
complementation phenomenon that is explained by the
fact that the tagged TbPFR2 gene was not silenced, as it was
expressed from a coding sequence flanked by UTRs from
the expression vector: from the 5' UTR of the procyclin
gene and from the 3'UTR of the aldolase gene (Figure 1B;
[57]).
To definitely demonstrate that the complementation
described above is indeed due to the expression of func-
tional TbPFR2-TAG, we transfected the same dsRNA into
TbPFR2tag-∆HLA  trypanosomes expressing a modified
TbPFR2 protein missing three amino acids (that is nine
nucleotides out of 1800). TbPFR2tag-∆HLA does not
access the flagellar compartment and thus cannot be func-
tional [58]. Transfecting either CDS dsRNA or UTRs MIX
dsRNAs produced cells in which the new flagellum was
not (or faintly) decorated by the anti-TbPFR2 antibody
(Table 2). TbPFR2-TAG-∆HLA was not decorated by the
anti-TAG antibody when cells were transfected with CDS
dsRNA (red color, Figure 4E), indicating that both the WT
and the tagged TbPFR2 copies were silenced, thus leading
to an incomplete PFR edification (yellow color, Figure
4E). In contrast, transfection of UTRs MIX dsRNAs did not
prevent the expression of the recombinant TbPFR2-TAG-
∆HLA protein, as it appeared stained by the anti-TAG anti-
body (red color, Figure 4F). However, that non-functional
protein could not participate in the construction of the
PFR, as shown by the absence of ROD-1 signal in the new
TbPFR2 silencing by targeting its UTRs all together Figure 3
TbPFR2 silencing by targeting its UTRs all together. WT cells were transfected with GFP dsRNA (A), CDS dsRNA (B) 
or UTRs MIX dsRNAs (C). At 14 h post-transfection, cells were treated for immunofluorescence using the L8C4 anti-TbPFR2 
antibody (green) and counterstained with DAPI (blue). Cells of interest are bi-nucleated/bi-flagellated. Transfection of GFP 
dsRNA did not produce any specific phenotype. Both the CDS dsRNA and the UTRs MIX dsRNAs successfully silenced 
TbPFR2. Scale bar: 10 µm. See text for details.BMC Biotechnology 2005, 5:6 http://www.biomedcentral.com/1472-6750/5/6
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flagellum, since it cannot access the flagellum (yellow
color, Figure 4F).
RNA-directed RNA polymerase activity (RdRP) has been
implicated as one possible step in the formation of siRNA
in fungi [59], plants [17,18], and worms [60]. The fact
that we could specifically silence WT TbPFR2 by targeting
its UTRs, without interfering with the tagged TbPFR2
genes, suggests that spreading of silencing beyond the ini-
tial targeted sequence does not occur in trypanosomes
[61-64].
Functional complementation with orthologue genes
We next asked if an RNAi-mediated loss of function could
be complemented by the expression of a gene orthologue
to the silenced one. The system used to answer that ques-
tion involved the TbPFR2i  cell line – that expresses
TbPFR2 dsRNA under the control of a tetracycline-induci-
ble promoter [47] – into which constitutive expression of
Trypanosoma cruzi TbPFR2 orthologue (TcPFR2) was estab-
lished using stable transfection procedures. TbPFR2 and
TcPFR2 proteins share 90 % identity (both of them are
recognized by the anti-TbPFR2 L8C4 antibody), but their
gene sequences have diverged enough for us to envisage
that the RNAi-silencing of TbPFR2 would not affect signif-
icantly the introduced TcPFR2 gene (83 % overall nucle-
Structural complementation of RNAi mutants Figure 4
Structural complementation of RNAi mutants. TbPFR2tag (panels A–C) or TbPFR2tag-∆HLA (panels D–F) cells were 
transfected with GFP dsRNA (first column), CDS dsRNA (second column) or UTRs MIX dsRNAs (last column). At 14 h post-
transfection, cells were treated for immunofluorescence with both the ROD-1 antibody (marker for full PFR assembly, yellow) 
and the BB2 anti-TAG antibody (red). All cells were counterstained with DAPI (blue). Cells of interest are bi-nucleated/bi-flag-
ellated. Transfection of GFP dsRNA (A, D) did not produce any specific phenotype, whatever the recipient cells: the paraflagel-
lar rod could assemble normally (yellow). As expected, TbPFR2-TAG localized to the flagellum (A, red), while TbPFR2-TAG-
∆HLA accumulated in the cytosol (D, red). The CDS dsRNA (B, E) successfully silenced the WT and the tagged TbPFR2 genes 
on both cell lines: no tagged TbPFR2 was stained with BB2; the paraflagellar rod could not assemble (no yellow signal is visible 
in the new flagellum). When using the UTRs MIX dsRNAs in TbPFR2tag and TbPFR2tag-∆HLA cells, the wild-type TbPFR2 gene is 
silenced (see Figure 3). However, only in the TbPFR2tag cells does TbPFR2-TAG complement the missing TbPFR2 protein: 
TbPFR2-TAG was stained in the flagellum in (C, red). TbPFR2-TAG-∆HLA failed to complement in the TbPFR2tag-∆HLA cells: 
TbPFR2-TAG-∆HLA was stained in the cytoplasm in (F, red). Thus, the paraflagellar rod could assemble fully in (C, yellow) but 
failed to do so in (F, yellow). Scale bar: 10 µm.BMC Biotechnology 2005, 5:6 http://www.biomedcentral.com/1472-6750/5/6
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otide identity). We thus created two new cell lines based
on the previously described TbPFR2i cells [47] (see Meth-
ods). TbPFR2 expression and cell motility were analyzed.
Our first experiment showed that the PCGFP cells consti-
tutively expressed GFP, as detected by microscope obser-
vation of living cells (data not shown). Both the PCGFP
and PCTcPFR2 cell lines were induced to express TbPFR2
dsRNA for 48 hours. Immunofluorescence revealed that
non-induced  PCGFP  cells exhibit a WT-like phenotype
(Figure 5A, -TET). When these cells were induced with tet-
racycline, expected TbPFR2 silencing occurred (Figure 5A,
+TET). Non-induced PCTcPFR2 cells displayed an intense
anti-TbPFR2 antibody decoration with bright dots in the
cytoplasm, indicative of TcPFR2 overexpression (such
overexpression by the EP procyclin promoter is frequent;
Figure 5B, -TET). When these same cells were tetracycline-
induced, the flagellar staining was still perfectly visible, at
a level comparable to the one previously observed in the
non-induced  PCGFP  control cells (Figure 5B, +TET).
Bright dots previously observed had disappeared, proba-
bly as a result of TbPFR2 silencing. The fact that the para-
flagellar rod was still neatly decorated by the anti-TbPFR2
antibody demonstrated that the structural  inter-species
Interspecies structural complementation of RNAi mutants Figure 5
Interspecies structural complementation of RNAi mutants. TbPFR2i-derived trypanosomes, constitutively expressing 
GFP (panel A; PCGFP cells) or TcPFR2 (panel B; PCTcPFR2 cells) were cultured for 48 h in the absence (-TET) or in the presence 
(+TET) of tetracycline. In these TbPFR2i-derived cells, tetracyline-induction triggers RNAi-silencing of the endogenous TbPFR2 
gene. The cells were then treated for immunofluorescence using L8C4 as an anti-TbPFR2 (right panel, black background) and 
counterstained with DAPI (left panel, merged with phase contrast image). Non-induced PCGFP cells show normal flagellar stain-
ing (A, -TET) while induced cells show an almost total loss of flagellar signal (A, +TET) due to silencing of TbPFR2. Non-induced 
PCTcPFR2 cells show an intense L8C4 signal in the flagellum and sometimes in the cytoplasm, due to overexpression (B, -TET). 
Upon tetracycline-induction of these cells, the flagellar L8C4 decoration did not disappear, indicating that TcPFR2 was not sub-
ject to RNAi and that TcPFR2 could successfully localize to the flagellum (B, +TET).BMC Biotechnology 2005, 5:6 http://www.biomedcentral.com/1472-6750/5/6
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complementation had indeed taken place in these cells,
with TcPFR2 being effectively located at the flagellum.
Did these structurally-complemented cells show a func-
tional complementation, i.e. a normal flagellum motility
(hence a normal cellular mobility)? To address this ques-
tion, we performed a sedimentation assay [56] on non-
induced and tetracycline-induced PCGFP and PCTcPFR2
trypanosomes (Figure 6). Non-induced PCGFP  cells
showed a little tendency to sediment due to the fact that
expression of TbPFR2 dsRNA in TbPFR2i cells is partially
leaky, producing low amounts of TbPFR2 dsRNA even in
the absence of tetracycline ([43]; Durand-Dubief and Bas-
tin, unpublished data). When expression of TbPFR2
dsRNA was fully induced, motility stopped leading to
increased sedimentation (Figure 6, left panel). In contrast,
expression of TbPFR2 dsRNA in PCTcPFR2 cells did not
reduce motility (Figure 6, right panel). That result defi-
nitely demonstrates that the ortholog protein TcPFR2
fully complemented the loss of function resulting from
TbPFR2 silencing.
The complementation described above shows the robust-
ness of our strategy, because TbPFR2 and TcPFR2 are
highly similar (they share 82 % identity at the nucleotide
level [65]) and are nonetheless correctly differenciated by
the RNAi machinery. However, our complementation
strategy might be more diffcult to implement when the
gene studied is too similar to the T. brucei counterpart.
While this unfavorable case might happen with extremely
evolutionarily-related organisms, studies have shown that
the overall genetic sequence identity between Trypanosoma
brucei and Trypanosoma cruzi, for example (the closest evo-
lutionarily-related organisms envisaged for these studies),
is roughly 80 % ([65] and [66]). [47] showed that this
identity percentage is still compatible with an RNAi-based
complementation strategy. It goes without saying that
when the organisms are evolutionarily-distant, gene
sequences diverge more rapidly than the protein
sequences, thus laying off a field where our strategy can be
implemented with good confidence that complementa-
tion will occur.
Conclusions
In this report, we demonstrated that RNAi-mediated
silencing of a gene by targeting its UTRs is useful in studies
where the loss of function resulting from this silencing
must be complemented with the expression of an RNAi-
resistant copy of the silenced gene, in order to demon-
strate that the phenotype is indeed due to silencing of that
gene, and not to inactivation of another one. The results
obtained in this work are of particular interest when
reverse-genetics studies cannot be easily achieved in
organisms not amenable to RNAi, like Leishmania [67] or
Trypanosoma cruzi [68], or where genetics experiments are
hardly set up, like mammals. When genes from these
organisms are to be studied, a complementation
experiment can be set up as a three-step procedure
whereby: 1) the ortholog gene in Trypanosoma brucei is
RNAi-silenced and the loss-of-function phenotype is
established; 2) T. brucei cells are engineered to ensure con-
stitutive heterologous expression of the gene of interest,
still allowing RNAi-mediated silencing of the T. brucei
gene; 3) function of the investigated gene is assessed by
checking if the loss-of-function phenotype observed in
the first place gets complemented. Additionally, one
application of the strategy described herein is genetic
functional dissection, which is of interest when protein
domains are to be characterized with respect to their func-
tion (e.g. the HLA tripeptide sequence in TbPFR2 that
localizes the protein to the flagellum).
Complementation had previously been demonstrated fol-
lowing transformation of mammalian cells with EGFP
siRNA and expression of a codon-modified, but func-
tional, EGFP version [69]. Our strategies are increasing
flexibility for complementation studies after RNAi as
unmodified genes can be used for rescue.
Methods
Trypanosomes
The procyclic T. brucei brucei strain 427 (or its derivatives)
was used throughout this work. Cells were cultured at
27°C in semi-defined medium 79 (SDM 79) containing
10% foetal calf serum. PFRAi cells were described in [47].
Phenotype analysis by sedimentation assay Figure 6
Phenotype analysis by sedimentation assay. PCGFP and 
PCTcPFR2 trypanosomes were induced (+Tet) with tetracy-
cline for 48 h or non-induced (-Tet) and grown in cuvettes. 
Non-motile cells do not swim and sediment to the bottom of 
the cuvette, leading to a reduction in optical density that can 
be monitored over time. The PCTcPFR2 cells show an almost 
perfect functional complementation phenotype, as induced 
and non-induced cells had virtually identical sedimentation 
curves.BMC Biotechnology 2005, 5:6 http://www.biomedcentral.com/1472-6750/5/6
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The TbPFR2i trypanosomes can be tetracycline-induced to
express TbPFR2 dsRNA, thus eliciting an RNAi response
against that gene. Note that this cell line is referred to as
TbPFR2i in this article because of a change in the gene
nomenclature [70].
RNAi assays by transient transfection
RNA was synthesized in vitro with T3 and Sp6 polymerases
using PCR products as templates [71]. The following
primers (incorporating T3 or Sp6 promoters) were used:
for GFP (from the nucleotide coding sequence 476–691 of
the EGFPN2 gene; Clontech), AATTAACCCTCACTAAAG-
GGAGAAG AACGGCATCAAGGTGAAC (T3 promoter ital-
icized) and ATTTAGGTGACACTATAGAAG
AGTGATCCCGGCGGCGGTCACG (Sp6 promoter
italicized);
for  FLA1,  AATTAACCCTCACTAAAGGGAGA  CCAAAC-
CGTGGGCACCAAGG (T3 promoter italicized) and ATT-
TAGGTGAACTATAGAAGAG
GTGGGATGATTAAAACGAGC (Sp6 promoter italicized);
for the TbPFR2 5' untranslated region (5' UTR; nucleotide
sequence [-545→-1] upstream of TbPFR2  ATG start
codon), AATTAACCCTCACTAAAGGGAGA (T3 promoter)
and ATTTAGGTGACACT-ATAGAAGAG (Sp6 promoter);
for the TbPFR2 intergenic untranslated region (igUTR),
AATTAACCCTCACTAAAGGGAGA  CGCTGCGCTTAAAT-
GTCTT (T3 promoter italicized) and ATTTAGGTGACAC-
TATAGAAGA GTGATGCTTTATTGCTTTCT (Sp6 promoter
italicized);
for the TbPFR2 3'untranslated region (3'UTR; nucleotide
sequence [1→533] downstream of the TbPFR2 TAG stop
codon), AATTAACCCTCACTAAAGGGAGA (universal T3
promoter) and ATTTAGGTGACACTATAGAAGAG  (uni-
versal Sp6 promoter);
for the TbPFR2 coding sequence (CDS; nucleotide coding
sequence [1084→1358]),  ATTTAGGTGACACTATAGA
GAGGTGAAGCGCCGTATTGAGGA (Sp6 promoter itali-
cized) and AATTAACCCTCACTAAAGGGAGA GTTTTGTA-
CAGGCGACGGAA (T3 promoter italicized);
Figure 1A shows the TbPFR2 locus and the position of the
two dsRNA populations that were used, and their homol-
ogy to either the coding sequence (labelled "CDS
dsRNA") or the different 5'UTR, igUTR and 3'UTR all
together (labelled "UTRs MIX dsRNAs"). A third dsRNA,
homologous to the GFP gene is labelled "GFP dsRNA"
throughout this work and was used as a control dsRNA.
dsRNA was introduced into trypanosomes by electropora-
tion, as described [14].
Plasmids
Plasmid pPC was generated from plasmid pSk1-GFP [50]
as follows: pSk1-GFP was digested with Hind III and Eco
RI to remove the GFP  gene. Oligonucleotides AGCT
GTCTAGCGATATCGGATCCG (forward) and AATT
CGGATCCGATATCGCTAGCA (reverse) were annealed
(protruding ends italicized) and the resulting double-
strand oligonucleotide was ligated into the pSk1-GFP
plasmid, resulting in the insertion of a poly-linker con-
taining restriction sites Cla I, Hind III, Nhe I, Eco RV, Bam
HI and Eco RI (Branche and Bastin; unpublished data).
Plas-mid pPCTcPFR2 was generated as follows:
amplification of the TcPFR2 gene was performed using
Trypanosoma cruzi genomic DNA (kind gift of Cécile Gallet
and Philippe Grellier, MNHN) and the two primers
TcPFR2H (GAGTCTAAGCTTATGAGCTACAAGGAG-
GCATC) and TcPFR2ER (GCGTGGAATTCTTACTGTGT-
GATCTGCTGCAC). Both the amplified DNA fragment
and the pPC plasmid were digested with Eco RI and Hind
III. The fragment was ligated into pPC so as to yield the
plasmid pPCTcPFR2 (Figure 1B).
Cell lines
The different constructs used to transform trypanosomes
are shown on Figure 1B. The cell lines were established as
follows.
WT-derived trypanosomes constitutively expressing TbPFR2-TAG 
proteins
The TbPFR2tag cell line was derived from the WT cell line
into which the pTbPFR2TAG430 plasmid [72] was trans-
fected. The recombinant cells constitutively expressed the
TbPFR2-TAG protein, that is localized in the flagellum
(Fig 4D). Tagged TbPFR2 is known to be functional
[56,72]. In contrast, transformation of WT cells with the
pTbPFR2TAG∆HLA430 plasmid lead to the expression of
slightly modified TbPFR2 protein, missing only three
amino acids, that failed to enter the flagellum compart-
ment and hence was found in the cell body cytoplasm
[58] (Fig 4G). This cell line was called TbPFR2tag-∆HLA.
After electroporation [73], cells were grown overnight and
then distributed in 24-well plates in the presence of phle-
omycin (2 µg/mL) for selection.
TbPFR2i-derived trypanosomes constitutively expressing GFP and 
TcPFR2
TbPFR2i cells [47] constituted the genetic background into
which we established the PCGFP and PCTcPFR2 new cell
lines. The PCGFP cell line was established by transfecting
TbPFR2i  cells with plasmid pPCGFP after linearization
with BstX I. For establishing the PCTcPFR2 cell line, the
pPCTcPFR2 plasmid was linearized with BstX I and trans-
fected into TbPFR2i cells. Recombinant cells were selected
by addition of puromycin (1 µg/mL), phleomycin (2 µg/BMC Biotechnology 2005, 5:6 http://www.biomedcentral.com/1472-6750/5/6
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mL), G418 (15 µg/mL) and hygromycin (20 µg/mL) to
the culture medium.
Immunofluorescence and microscopy
Three different monoclonal antibodies were used as
hybridoma supernatants: L8C4, IgG recognizing T. brucei
TbPFR2 and cross-reacting with T. cruzi orthologue
TcPFR2 [74]; BB2, IgG recognizing the Ty-1 tag of the
TbPFR2-TAG and TbPFR2-TAG-∆HLA recombinant pro-
teins [54]; and ROD-1, IgM recognizing a doublet of
minor PFR proteins [55]. For immunofluorescence,
trypanosomes were spread onto poly-L-lysine-coated
slides, fixed in cold methanol and processed as described
[75]. Experiments involving the use of L8C4 only were
performed with an FITC-conjugated anti-mouse IgG sec-
ondary antibody. Double-staining experiments using BB2
and ROD-1 were performed with a TRITC-conjugated spe-
cific anti-mouse IgG secondary antibody and an FITC-
conjugated specific anti-mouse IgM secondary antibody.
DNA was systematically stained with 4',6-diamidino-2-
phenylindole (DAPI). Slides were examined with a Leica
DMR microscope, images were captured using a cooled
CCD camera (Cool Snap HQ, Roper Scientific) and
processed with the GNU image manipulation program
version 2 [76].
Cell sedimentation assay
The trypanosome sedimentation assay was performed as
described in [56]. Briefly: trypanosomes were grown at ≈
5.106 cells/mL in normal culture medium, with or with-
out 48 hour tetracycline induction. 1 mL of these cultures
was dispensed to 5 plastic spectrophotometry cuvettes, for
time points 0, 2, 4, 6, 8 hours, and left still. At each time
point, the optical density at 600 nm was measured twice:
first without mixing (O.D.no mix) and second after mixing
the cuvette (O.D.mix). Data were plotted as a function of
time.
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